These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

282 related items for PubMed ID: 11884485

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Inhibitory role of CD19 in the progression of experimental autoimmune encephalomyelitis by regulating cytokine response.
    Matsushita T, Fujimoto M, Hasegawa M, Komura K, Takehara K, Tedder TF, Sato S.
    Am J Pathol; 2006 Mar; 168(3):812-21. PubMed ID: 16507897
    [Abstract] [Full Text] [Related]

  • 5. Role of IL-12 receptor beta 1 in regulation of T cell response by APC in experimental autoimmune encephalomyelitis.
    Zhang GX, Yu S, Gran B, Li J, Siglienti I, Chen X, Calida D, Ventura E, Kamoun M, Rostami A.
    J Immunol; 2003 Nov 01; 171(9):4485-92. PubMed ID: 14568921
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. MOG extracellular domain (p1-125) triggers elevated frequency of CXCR3+ CD4+ Th1 cells in the CNS of mice and induces greater incidence of severe EAE.
    Mony JT, Khorooshi R, Owens T.
    Mult Scler; 2014 Sep 01; 20(10):1312-21. PubMed ID: 24552747
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Role of MOG-stimulated Th1 type "light up" (GFP+) CD4+ T cells for the development of experimental autoimmune encephalomyelitis (EAE).
    Yura M, Takahashi I, Serada M, Koshio T, Nakagami K, Yuki Y, Kiyono H.
    J Autoimmun; 2001 Aug 01; 17(1):17-25. PubMed ID: 11488634
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Rat and human myelin oligodendrocyte glycoproteins induce experimental autoimmune encephalomyelitis by different mechanisms in C57BL/6 mice.
    Oliver AR, Lyon GM, Ruddle NH.
    J Immunol; 2003 Jul 01; 171(1):462-8. PubMed ID: 12817031
    [Abstract] [Full Text] [Related]

  • 12. Tyrosine kinase 2 plays critical roles in the pathogenic CD4 T cell responses for the development of experimental autoimmune encephalomyelitis.
    Oyamada A, Ikebe H, Itsumi M, Saiwai H, Okada S, Shimoda K, Iwakura Y, Nakayama KI, Iwamoto Y, Yoshikai Y, Yamada H.
    J Immunol; 2009 Dec 01; 183(11):7539-46. PubMed ID: 19917699
    [Abstract] [Full Text] [Related]

  • 13. Host T cells are the main producers of IL-17 within the central nervous system during initiation of experimental autoimmune encephalomyelitis induced by adoptive transfer of Th1 cell lines.
    Lees JR, Iwakura Y, Russell JH.
    J Immunol; 2008 Jun 15; 180(12):8066-72. PubMed ID: 18523270
    [Abstract] [Full Text] [Related]

  • 14. Cytosolic phospholipase A2 alpha-deficient mice are resistant to experimental autoimmune encephalomyelitis.
    Marusic S, Leach MW, Pelker JW, Azoitei ML, Uozumi N, Cui J, Shen MW, DeClercq CM, Miyashiro JS, Carito BA, Thakker P, Simmons DL, Leonard JP, Shimizu T, Clark JD.
    J Exp Med; 2005 Sep 19; 202(6):841-51. PubMed ID: 16172261
    [Abstract] [Full Text] [Related]

  • 15. CD134 plays a crucial role in the pathogenesis of EAE and is upregulated in the CNS of patients with multiple sclerosis.
    Carboni S, Aboul-Enein F, Waltzinger C, Killeen N, Lassmann H, Peña-Rossi C.
    J Neuroimmunol; 2003 Dec 19; 145(1-2):1-11. PubMed ID: 14644025
    [Abstract] [Full Text] [Related]

  • 16. VPAC1 receptor (Vipr1)-deficient mice exhibit ameliorated experimental autoimmune encephalomyelitis, with specific deficits in the effector stage.
    Abad C, Jayaram B, Becquet L, Wang Y, O'Dorisio MS, Waschek JA, Tan YV.
    J Neuroinflammation; 2016 Jun 29; 13(1):169. PubMed ID: 27357191
    [Abstract] [Full Text] [Related]

  • 17. Resistance to myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis by death receptor 6-deficient mice.
    Schmidt CS, Zhao J, Chain J, Hepburn D, Gitter B, Sandusky G, Chintalacharuvu S, Glasebrook A, Na S.
    J Immunol; 2005 Aug 15; 175(4):2286-92. PubMed ID: 16081797
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Recombinant TCR ligand induces tolerance to myelin oligodendrocyte glycoprotein 35-55 peptide and reverses clinical and histological signs of chronic experimental autoimmune encephalomyelitis in HLA-DR2 transgenic mice.
    Vandenbark AA, Rich C, Mooney J, Zamora A, Wang C, Huan J, Fugger L, Offner H, Jones R, Burrows GG.
    J Immunol; 2003 Jul 01; 171(1):127-33. PubMed ID: 12816990
    [Abstract] [Full Text] [Related]

  • 20. IFN-inducible protein 10/CXC chemokine ligand 10-independent induction of experimental autoimmune encephalomyelitis.
    Klein RS, Izikson L, Means T, Gibson HD, Lin E, Sobel RA, Weiner HL, Luster AD.
    J Immunol; 2004 Jan 01; 172(1):550-9. PubMed ID: 14688366
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.